Carrie Haskell-Luevano
Affiliations: | Medicinal Chemistry | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
peptide hormone endocrine systems in the brain, and their involvement in feeding behavior, exercise, diabetes, and obesityWebsite:
http://www.pharmacy.umn.edu/medchem/directory/faculty/haskell-luevano/Google:
"Carrie Haskell-Luevano"Mean distance: 9.96 | S | N | B | C | P |
Parents
Sign in to add mentorVictor J. Hruby | grad student | 1995 | University of Arizona |
Roger D. Cone | post-doc | OHSU |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ericson MD, Freeman KT, LaVoi TM, et al. (2023) The Parallel Structure-Activity Relationship Screening of Three Compounds Identifies the Common Agonist Pharmacophore of Pyrrolidine Bis-Cyclic Guanidine Melanocortin-3 Receptor (MC3R) Small-Molecule Ligands. International Journal of Molecular Sciences. 24 |
Ericson MD, Tran LT, Mathre SS, et al. (2023) Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH] at the MC1R, MC3R, MC4R, and MC5R that Mediates an Increased Feeding Response in Mice and a 40-Fold Selective MC1R Antagonist [Ac-DPhe(pI)-DArg-Nal(2')-Arg-NH]. Journal of Medicinal Chemistry |
Ericson MD, Larson CM, Freeman KT, et al. (2022) Incorporation of Indoylated Phenylalanine Yields a Sub-Micromolar Selective Melanocortin-4 Receptor Antagonist Tetrapeptide. Acs Omega. 7: 27656-27663 |
Ericson MD, Doering SR, Larson CM, et al. (2021) Functional Mixture-Based Positional Scan Identifies a Library of Antagonist Tetrapeptide Sequences (LAtTeS) with Nanomolar Potency for the Melanocortin-4 Receptor and Equipotent with the Endogenous AGRP(86-132) Antagonist. Journal of Medicinal Chemistry |
Doering SR, Freeman K, Debevec G, et al. (2021) Discovery of Nanomolar Melanocortin-3 Receptor (MC3R)-Selective Small Molecule Pyrrolidine Bis-Cyclic Guanidine Agonist Compounds Via a High-Throughput "Unbiased" Screening Campaign. Journal of Medicinal Chemistry |
Koikov L, Starner RJ, Swope VB, et al. (2021) Development of hMC1R Selective Small Agonists for Sunless Tanning and Prevention of Genotoxicity of UV in Melanocytes. The Journal of Investigative Dermatology |
Ericson MD, Shaikh R, Larson CM, et al. (2021) Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 over Melanocortin-4 Receptor Agonist. Acs Medicinal Chemistry Letters. 12: 115-120 |
Ericson MD, Haslach EM, Schnell SM, et al. (2021) Discovery of Molecular Interactions of the Human Melanocortin-4 Receptor (hMC4R) Asp189 (D189) Amino Acid with the Endogenous G-Protein-Coupled Receptor (GPCR) Antagonist Agouti-Related Protein (AGRP) Provides Insights to AGRP's Inverse Agonist Pharmacology at the hMC4R. Acs Chemical Neuroscience. 12: 542-556 |
Ericson MD, Freeman KT, Haskell-Luevano C. (2020) Peptoid NPhe in AGRP-Based c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Scaffolds Maintain Mouse MC4R Antagonist Potency. Acs Medicinal Chemistry Letters. 11: 1942-1948 |
Adank DN, Lunzer MM, Ericson MD, et al. (2020) Comparative intracerebroventricular (ICV) and intrathecal (IT) administration of a nanomolar macrocyclic melanocortin receptor agonist MDE6-5-2c (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro]) decreases food intake in mice. Acs Chemical Neuroscience |